MULTIHANCE
BRACCO IMAGING CANADA
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MULTIHANCE in Canada?
Yes. MULTIHANCE 529MG has an active shortage reported to Health Canada (last updated October 1, 2025).
When will MULTIHANCE be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02248302
Strength
529MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Active Ingredient
GADOBENATE DIMEGLUMINE
Tier
Unrated
Last Updated
2025-10-01
Reason for Shortage
Other (Please describe in comments)
Past Reports for This Drug
MULTIHANCE has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from BRACCO IMAGING CANADA
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
52% · DIN 02228556
DIN 02228564
41% · DIN 02229013
61% · DIN 02229021
76% · DIN 02229048
61% · DIN 02242122
76% · DIN 02242121
5MCG · DIN 02228602
279.3MG · DIN 02229056
DIN 02228599
8MCL · DIN 02287684
485.1MG · DIN 02567334